The Epidemiology of Peripheral Arterial Disease: Importance of Identifying the Population at Risk

Data from the Framingham Study and other population studies indicate that intermittent claudication (IC) sharply increases in late middle age and is somewhat higher among men than women. Noninvasive testing in populations indicates that the true prevalence of peripheral arterial disease (PAD) is at least five times higher than would be expected based on the reported prevalence of IC. Peripheral arterial disease correlates most strongly with cigarette smoking and either diabetes or impaired glucose tolerance. Other risk factors for PAD include hypertension; low levels of high-density lipoprotein cholesterol; and high levels of triglycerides, apolipoprotein B, lipoprotein(a), homocysteine, fibrinogen and blood viscosity. Individuals with PAD are more likely to have coronary heart disease and cerebrovascular disease than those without PAD. Because of the high risk of both nonfatal and fatal cardiovascular disease (CVD) events in PAD patients, individuals with evidence of PAD should undergo both a careful examination of the entire cardiovascular system and aggressive modification of CVD risk factors.

[1]  R. Hamman,et al.  Effect of diagnostic criteria on the prevalence of peripheral arterial disease. The San Luis Valley Diabetes Study. , 1995, Circulation.

[2]  R. Langer,et al.  Screening for peripheral arterial disease: the sensitivity, specificity, and predictive value of noninvasive tests in a defined population. , 1994, American journal of epidemiology.

[3]  S. Grundy,et al.  Lp(a) lipoprotein is an independent, discriminating risk factor for premature peripheral atherosclerosis among white men. , 1994, Archives of internal medicine.

[4]  L. Kuller,et al.  Decreased ankle/arm blood pressure index and mortality in elderly women. , 1993, JAMA.

[5]  J. Mckenney,et al.  Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II) , 1993, JAMA.

[6]  F. Violi,et al.  Effect of Picotamide on the Clinical Progression of Peripheral Vascular Disease A Double‐Blind Placebo‐Controlled Study , 1993 .

[7]  P. Donnan,et al.  Blood Viscosity, Fibrinogen, and Activation of Coagulation and Leukocytes in Peripheral Arterial Disease and the Normal Population in the Edinburgh Artery Study , 1993, Circulation.

[8]  R. Langer,et al.  Mortality over a Period of 10 Years in Patients with Peripheral Arterial Disease , 1992 .

[9]  J. Manson,et al.  Low-dose aspirin and subsequent peripheral arterial surgery in the Physicians' Health Study , 1992, The Lancet.

[10]  L. Kuller,et al.  The ratio of ankle and arm arterial pressure as an independent predictor of mortality. , 1991, Atherosclerosis.

[11]  R. Langer,et al.  Large Vessel and Isolated Small Vessel Disease , 1991 .

[12]  M J Shipley,et al.  Intermittent claudication, heart disease risk factors, and mortality. The Whitehall Study. , 1990, Circulation.

[13]  J P Matts,et al.  Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH) , 1990, The New England journal of medicine.

[14]  G. Masotti,et al.  Current Therapy of Peripheral Obstructive Arterial Disease. The Non-Surgical Approach , 1990, Angiology.

[15]  E. Barrett-Connor,et al.  Peripheral arterial disease in large vessels is epidemiologically distinct from small vessel disease. An analysis of risk factors. , 1989, American journal of epidemiology.

[16]  L. Taylor,et al.  Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease. , 1989, Circulation.

[17]  M. Bousser,et al.  Fate of the patient with chronic leg ischaemia. A review article. , 1989, The Journal of cardiovascular surgery.

[18]  G. Reaven.  Role of Insulin Resistance in Human Disease , 1988, Diabetes.

[19]  W C Willett,et al.  Low-density lipoprotein subclass patterns and risk of myocardial infarction. , 1988, JAMA.

[20]  T. Schroeder,et al.  Fate in intermittent claudication: outcome and risk factors. , 1986, British medical journal.

[21]  S. Coughlin,et al.  Noninvasively diagnosed peripheral arterial disease as a predictor of mortality: results from a prospective study. , 1985, Circulation.

[22]  E. Barrett-Connor,et al.  TABLE 1 Prevalence of PAD by traditional assessment : intermittent claudication and pulse palpation % Claudication % Pulse abnormalities Rose Femoral Posterior Dorsalis n Rose , 2005 .

[23]  E. Barrett-Connor,et al.  The sensitivity, specificity, and predictive value of traditional clinical evaluation of peripheral arterial disease: results from noninvasive testing in a defined population. , 1985, Circulation.

[24]  Rifkind Bm.  The Lipid Research Clinics Coronary Primary Prevention Trial: results and implications. , 1985 .

[25]  S. Soimakallio,et al.  Correlation of angiographically determined reduction of vascular lumen with lower-limb systolic pressures. , 1985, Acta chirurgica Scandinavica.

[26]  A. Reunanen,et al.  Prevalence of intermittent claudication and its effect on mortality. , 2009, Acta medica Scandinavica.

[27]  J. Mann,et al.  Intermittent claudication: prevalence and risk factors. , 1978, British medical journal.

[28]  W. Kannel,et al.  Intermittent claudication. Surgical significance. , 1974, Archives of surgery.

[29]  H. Keen,et al.  Cardiorespiratory disease and diabetes among middle-aged male Civil Servants. A study of screening and intervention. , 1974, Lancet.

[30]  E F Bernstein,et al.  Noninvasive physiologic tests in the diagnosis and characterization of peripheral arterial occlusive disease. , 1973, American journal of surgery.

[31]  W. Kannel,et al.  Intermittent Claudication: Incidence in the Framingham Study , 1970, Circulation.

[32]  J. Ludbrook,et al.  Significance of Absent Ankle Pulse , 1962, British medical journal.